Oral direct inhibitors of coagulation
| Autor: | HG Watson |
|---|---|
| Rok vydání: | 2014 |
| Předmět: |
Rivaroxaban
Pyridines Pyridones business.industry Morpholines Administration Oral Anticoagulants Atrial fibrillation Thiophenes General Medicine medicine.disease Dabigatran Education Coagulation Anesthesia medicine Humans Pyrazoles Benzimidazoles Apixaban business Venous thromboembolism medicine.drug |
| Zdroj: | The Journal of the Royal College of Physicians of Edinburgh. 44:46-49 |
| ISSN: | 2042-8189 1478-2715 |
| DOI: | 10.4997/jrcpe.2014.111 |
| Popis: | For the first time in 50 years new oral anticoagulants of proven efficacy and with acceptable safety profiles are available for patients with atrial fibrillation and venous thromboembolism. Here is a brief overview of the benefits and possible disadvantages of using these drugs. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|